1. Home
  2. Live Updates
  3. Sun pharma share price

Live Breaking News & Updates on Sun pharma share price

Stay informed with the latest breaking news from Sun pharma share price on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Sun pharma share price and stay connected to the pulse of your community

sun pharma q3 results: Sun Pharma Q3 Results: Cons PAT rises 17% YoY to Rs 2,561 crore; Rs 8.5/sh dividend announced

Sun Pharmaceutical Industries reported a 17.4% YoY growth in net profit for Q4, beating estimates. Consolidated revenue grew 10% YoY. The company recommended an interim dividend payout. EBITDA rose 16% YoY and margins expanded. Raw material cost fell, but staff cost increased. India formulation sales and US formulation sales grew, while emerging markets formulation sales declined.

Mumbai , Maharashtra , India , Sun-pharmaceutical-industries-on , Pharmaceutical-industries , Sun-pharma-q3-results , Sun-pharma-q3-earnings , Sun-pharma-shares , Sun-pharmaceutical , Sun-pharma-share-price , Q3-earnings

Sun Pharma's m-cap crosses Rs 3 lakh crore mark, becomes 20th most valued company

The stock has rallied nearly 40% from its 52-week low of Rs 922.45, the stock hit in May, this year. Its one-year returns stand at 27% which is higher than 16% returns given by broader Nifty during this period while lower than the Nifty Pharma index which has given over 29% returns.

Sun-pharma , Sun-pharmaceuticals-industries , Sun-pharmaceutical-industries , Dilip-shanghvi-owned , Nifty-pharma , Pharmaceutical-industries , Sun-pharma-shares , Sun-pharma-share-price , Sun-pharma-stock , Sun-pharmam-cap , Markets-news ,

sun pharma share price: Hot Stocks: Brokerages view on Sun Pharma, Hero MotoCorp, IOC and Godrej Consumer

Jefferies maintained a buy rating on Sun Pharma with a target price of Rs 1310. The Q2 miss was largely on higher operating expenses.

Indonesia , India , Sun-pharma , Motilal-oswal , Morgan-stanley , Hero-motocorp , Godrej-consumer , Sun-pharma-share-price , Brokerages , Stock-recommendations , Stocks-to-buy , Sensex

Sun Pharma Q2: Sun Pharma Q2 Results: Cons profit rises 6% YoY to Rs 2,385 crore, beats estimates

Operating profit, calculated as earnings before interest, taxes, depreciation, and amortization (EBITDA), for the quarter, rose nearly 8% on year to Rs 3,179.30 crore, but operating margin contracted by 91 basis points to 26.08%. Total expenses in the quarter rose to Rs 9,695 crore, from Rs 8,625 crore a year ago.

Mumbai , Maharashtra , India , Dilip-shanghvi , Sun-pharma , National-stock-exchange-at-rs , Sun-pharmaceutical-industries-on , Pharmaceutical-industries , Pharmaceutical-ingredients , Emerging-markets , Row-markets , Managing-director

Israel-Hamas war: 9 listed companies that have exposure in the region

Experts do not anticipate a major impact of the war on the Indian market.

Gaza , Israel-general- , Israel , Gaza-strip , India , Bharat , Israeli , Larsen-toubro , Sun-pharma , Wipro , Infosys , Tata-consultancy-services

Sun Pharma Q1 Results: Sun Pharma Q1 Results: Cons PAT falls 2% YoY to Rs 2,023 crore on one-time expense

The fall in the bottomline was partly due to certain one-time charges totalling Rs 323 crore. The company also incurred a one-time transitional cost of Rs 51 crore on the relocation of Alchemee operations from California to New York.

New-york , United-states , Mumbai , Maharashtra , India , Sun-pharma , Dilip-shanghvi , Managing-director , Sun-pharma-q1-results , Sun-pharma-q1 , Sun-pharma-results

sun pharma q1 results: Sun Pharma Q1 preview: Weak Taro show, soft US sales to weigh on earnings

Consolidated net profit is seen declining 1.4% YoY to Rs 2,033 crore. Indias largest pharmaceutical company by market capitalization is scheduled to release its earnings on Thursday.

Halol , Gujarat , India , Mohali , Madhya-pradesh , Sun-pharma , Cequa-trx , Taro-pharmaceutical-industries , Sun-pharmaceutical-industrie , Drug-administration , Sun-pharma-q1-results , Sun-pharma-q1-preview

Top gainers, losers today: Adani Ent, HDFC twins, Sun Pharma, Indiabulls Real Estate; check full list here

Top gainers, losers today: Markets witnessed selling pressure on Wednesday due to decline in banking and financial stocks coupled with profit booking in Adani stocks. Consumer durables and healthcare shares were top gainers.

India , United-kingdom , Vinod-nair , Optiemus-infracom , Bajaj-finserv , Dishman-carbogen , Sun-pharma , Visesh-infotechnics , Sudarshan-chemical-industries , Polyplex-corp , Schneider-electric , Head-of-research-at-geojit-financial-services

Sun Pharma temporarily pauses shipments from Mohali facility after US FDA issues corrective actions letter

Sun Pharma said, the company is taking required corrective steps, but there will be a temporary pause in the release of batches from Mohali until US FDA-mandated measures are implemented.

Sun-pharma-mohali , Sun-pharma , Sun-pharma-mohali-facility-shipments-halted , Sun-pharma-halts-shipments-from-mohali-facility , Sun-pharma-mohali-facility-us-fda-inspection , Sun-pharma-share-price , Sun-pharma-mohali-facility , Sun-pharma-mohali-facility-inspections , Sun-pharma-market-cap ,

Sun Pharma Share Price, Sun Pharma Stock Price, Sun Pharmaceutical Industries Ltd. Stock Price, Share Price, Live BSE/NSE, Sun Pharmaceutical Industries Ltd. Bids Offers. Buy/Sell Sun Pharmaceutical Industries Ltd. news & tips, & F&O Quotes, NSE/BSE Forecast News and Live Quotes

Sun Pharma Share Price: Find the latest news on Sun Pharma Stock Price. Get all the information on Sun Pharma with historic price charts for NSE / BSE. Experts & Broker view also get the Sun Pharma Ltd. buy/sell tips detailed news, announcements, Forecasts, Analysts, Valuation, Earning forecasts, Estimates, Recommendations, Analysts Ratings, financial report, company information, annual report, balance sheet, profit & loss account, results and more.

Vikhroli , Maharashtra , India , Mumbai , Vadodra , Gujarat , Sun-pharma-advanced-research-centre , Pharma-advanced-research-centre , Intime-india , Sun-pharma-share-price , Un-pharma-stock-price